Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
Quantifying the direct and indirect economic costs of hypertension is essential to support public health interventions and address health disparities.
Hypertension, a major contributor to cardiovascular disease (CVD) including heart disease and stroke, is one of the leading contributors of global burden of disease and a growing public health problem worldwide.1 In the U.S., about 75.2 million adults (one in every three) had hypertension during 2013–2014.2 In 2014, hypertension was listed as a primary or contributing cause of 427,631 American deaths, and heart disease and stroke were the first- and fifth-leading causes of death respectively.3 Economically, hypertension cost the nation about $51.2 billion per year, and total CVD cost the nation about $316.1 billion per year during 2012–2013.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: